Jared Preston, MD
Adult Reconstructive Orthopaedic Surgery · New Providence, NJNPI 1063828762
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (39.6%), education and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Stryker at 49.7% of the total.
Across 99 payments — averaging $120.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$6K
- Smith+Nephew$5K
- Bioventus LLC$357
- Zimmer Biomet$302
- Ferring Pharmaceuticals Inc.$194
- Medical Device Business Services, Inc.$175
- plus $459 from 11 others
What the payments were for
- Travel & lodging$2,50921%
- Food & beverage$4,71140%
- Education$4,67539%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 54 | $5,909 |
| Smith+Nephew | 1 | $4,500 |
| Bioventus LLC | 12 | $357 |
| Zimmer Biomet | 3 | $302 |
| Ferring Pharmaceuticals Inc. | 11 | $194 |
| Medical Device Business Services, Inc. | 1 | $175 |
| Innovation Technologies Inc | 2 | $133 |
| Johnson & Johnson | 2 | $97 |
| Sanofi-aventis U.S. LLC | 5 | $66 |
| Boston Scientific | 1 | $53 |
| Avanos Medical | 1 | $27 |
| Molnlycke Health Care US, LLC | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
| Paragon 28, Inc. | 1 | $14 |
| Vericel Corporation | 1 | $12 |
| Dynasplint Systems Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,895 in reported general payments places this provider in the 60th percentile of 39 adult reconstructive orthopaedic surgery providers in New Jersey.
See all adult reconstructive orthopaedic surgery providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 246 | $1,284 |
| Celecoxib | 55 | $898 |
| Diclofenac Sodium | 11 | $460 |
| Naproxen | 13 | $91 |
| Amoxicillin | 35 | $43 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in New Providence
- Jeffrey LearyNew Providence$148K
- Atul KamathManasquan$4M
- Alfred TriaSomerset$582K
- John DundonHackettstown$573K
- Ismar DizdarevicRidgewood$368K
- David FeldmanEnglewood$335K
- Mark PizzurroRidgewood$239K
- Timothy HendersonWayne$140K
- Anthony CostaEatontown$95K
- Gregory RoehrigManasquan$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.